Task: Answer the MCQ question.
Question: Which drug exhibits a 15.330\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) COC(=O)[C@H](CC(C)C)NC(=O)Nc1ccc(S(N)(=O)=O)cc1
b.) Cc1ccc(O)c(/C=N/NC(=O)CN2CCCC2)c1
c.) Cc1cc(Cl)ccc1OCCCC(=O)Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1
Answer: b. Cc1ccc(O)c(/C=N/NC(=O)CN2CCCC2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(O)c(/C=N/NC(=O)CN2CCCC2)c1
Cc1ccc(O)c(/C=N/NC(=O)CN2CCCC2)c1
N-[(E)-(2-hydroxy-5-methylphenyl)methylideneamino]-2-pyrrolidin-1-ylacetamide